Advertisement

BRIEF-Genomic Health and Biocartis announce agreement to develop a breast cancer test

BRIEF-Genomic Health and Biocartis announce agreement to develop a breast cancer test
From Reuters - September 12, 2017

Sept 13 (Reuters) - BIOCARTIS GROUP NV:

* GENOMIC HEALTH AND BIOCARTIS ANNOUNCE AGREEMENT TO DEVELOP AN IDYLLA(TM) IVD ONCOTYPE DX() BREAST CANCER TEST TO BROADEN GLOBAL PATIENT ACCESS

* EXCLUSIVE AGREEMENT TO DEVELOP AN IVD VERSION OF ONCOTYPE DX BREAST RECURRENCE SCORE TEST ON BIOCARTIS IDYLLA PLATFORM

* ONCOTYPE DX BREAST RECURRENCE SCORE TEST PLANNED FOR LAUNCH IN EUROPE BEGINNING WITH FRANCE AND GERMANY IN 2019

Advertisement

Continue reading at Reuters »